Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
My Person List (
0
)
Return to Top
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. N Engl J Med. 2025 Apr 03; 392(13):1261-1276.
View in:
PubMed
subject areas
Acetamides
Administration, Oral
Adolescent
Adult
Aged
Anti-HIV Agents
Double-Blind Method
Drug Administration Schedule
Drug Combinations
Emtricitabine
Female
HIV Infections
Humans
Incidence
Indazoles
Injection Site Reaction
Injections, Subcutaneous
Intention to Treat Analysis
Male
Middle Aged
Pre-Exposure Prophylaxis
Tenofovir
Transgender Persons
Treatment Outcome
Young Adult
authors with profiles
Lashonda Spencer, MD